Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000460361 | SCV000563730 | likely benign | BAP1-related tumor predisposition syndrome | 2024-01-17 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000564152 | SCV000672752 | likely benign | Hereditary cancer-predisposing syndrome | 2016-04-15 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV000564152 | SCV000908683 | likely benign | Hereditary cancer-predisposing syndrome | 2018-09-05 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV001821385 | SCV002070424 | likely benign | not specified | 2021-12-23 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003932774 | SCV004753758 | likely benign | BAP1-related condition | 2019-10-28 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |